Related Experiment Videos
Apoptosis in cardiac disease--what is it--how does it occur
1Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA.
Cardiovascular Drugs and Therapy
|March 28, 2002
Summary
This review summarizes apoptotic pathways in the heart, their measurement, and evidence linking programmed cell death to cardiac disease. It also evaluates therapies aimed at preventing apoptosis in heart conditions.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Death Research
Background:
- Apoptosis, or programmed cell death, plays a critical role in cardiac physiology and pathology.
- Dysregulation of apoptotic pathways is implicated in the development and progression of various cardiac diseases.
- Understanding these pathways is crucial for developing effective therapeutic strategies.
Purpose of the Study:
- To provide a comprehensive overview of apoptotic pathways in the heart.
- To review methods for measuring apoptosis in cardiac tissues.
- To evaluate the role of apoptosis in cardiac disease and assess therapeutic interventions.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of data on apoptotic markers and mechanisms in cardiac disease.
- Evaluation of pharmacological and non-pharmacological interventions targeting apoptosis.
Main Results:
- Apoptosis is a significant factor in numerous cardiac conditions, including heart failure and myocardial infarction.
- Various methods exist to quantify cardiac apoptosis, aiding in disease assessment.
- Evidence supports the involvement of specific apoptotic signaling cascades in cardiac pathology.
Conclusions:
- Targeting apoptotic pathways represents a promising therapeutic avenue for cardiac diseases.
- Further research is needed to optimize interventions aimed at modulating cardiac apoptosis.
- A deeper understanding of apoptosis mechanisms can lead to novel treatment strategies for heart conditions.